Gilead gave the money to doctors who spoke at HIV Speaker Program events in the form of honoraria payments, meals and travel expenses, according to the U.S. Attorney's Office in Manhattan, which ...

Gilead will fund the construction of three facilities, upgrades to three others and investments in technology and engineering. (Bloomberg News) Gilead Sciences said Wednesday it will invest $11 ...

and user acceptanc Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even ...

Drugmaker Gilead is adding to its promised investments in the U.S., vowing to spend another $11B on top of the $21B it has already committed to research, development and manufacturing.

Gilead's quarterly sales of HIV drug Biktarvy rose 7% to $3.15 billion, roughly in line with Wall Street estimates, while sales of liver disease drugs rose 3% to $758 million. The California-based ...